82846bc2cd68a3622614eab6bf0bf59e

MAS OMNI-IMMUNE LIQUID ASSAYED INTEGRATED IMMUNOASSAY CONTROL

MICROGENICS CORPORATION·II·Colombia INVIMA·Expires November 24, 2030
Device classification
Risk class / Clase de Riesgo
II
Product type (Spanish)
REACTIVO DIAGNOSTICO
Product type (English)
DIAGNOSTIC REAGENT
Registration information
Analysis ID
82846bc2cd68a3622614eab6bf0bf59e
Expire date
November 24, 2030
Authorized company / Fabricante
Name (English)
MICROGENICS CORPORATION
Product use / Uso del Producto
Spanish

DETERMINACIÓN DE LOS DIFERENTES ANALITOS RELACIONADOS CON MUESTRAS PROCEDENTES DEL ORGANISMO HUMANO

English

DETERMINATION OF THE DIFFERENT ANALYTES RELATED TO SAMPLES FROM THE HUMAN ORGANISM

About this record

Access comprehensive regulatory information for MAS OMNI-IMMUNE LIQUID ASSAYED INTEGRATED IMMUNOASSAY CONTROL (MAS OMNI-IMMUNE LIQUID ASSAYED INTEGRATED IMMUNOASSAY CONTROL) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID 82846bc2cd68a3622614eab6bf0bf59e and manufactured by MICROGENICS CORPORATION. The device was registered on November 24, 2030.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.